Drug search by name

RHo (D) immune globulin and Thromboembolism

Result of checking the interaction of drug RHo (D) immune globulin and disease Thromboembolism for safety when used together.

Check result:

RHo (D) immune globulin <> Thromboembolism

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of immune globulin intravenous products, including RHo (D) immune globulin may cause thromboembolism. Care should be taken when using these agents in patients with a history of atherosclerosis, multiple cardiovascular risk factors, advanced age, impaired cardiac output, coagulation disorders, prolonged periods of immobilization, and/or known/suspected hyperviscosity. It is recommended to assess blood viscosity in patients at risk of hyperviscosity and in those at risk of developing thromboembolic events, these agents should be administered at the minimum rate of infusion practicable.

RHo (D) immune globulin

Generic Name: rho (d) immune globulin

Brand Name: HyperRHO S/D Full Dose, HyperRHO S/D Mini Dose, MicRhoGAM, MicRhoGAM Ultra-Filtered Plus, RhoGAM, RhoGAM Ultra-Filtered Plus, Rhophylac, WinRho SDF, Gamulin Rh, Mini-Gamulin Rh, HypRho-D Mini-Dose, BayRho-D, BayRHo-D Full Dose, BayRHo-D Mini-Dose, Anti-D Immunoglobulin, D-Gam Anti-D, Partobulin SDF, Liberim D

Synonyms: Rho(D) Immune Globulin

What is RHo (D) immune globulin?